Results 31 to 40 of about 788 (151)

Efficacy and safety of ultrasound-guided popliteal sciatic nerve block in endovascular intervention for lower extremity arteriosclerosis obliterans [PDF]

open access: yes精准医学杂志
Objective To investigate the efficacy and safety of ultrasound-guided popliteal sciatic nerve block (PSNB) in endovascular intervention for lower extremity arteriosclerosis obliterans (LEAO).
FU Chunmeng, WANG Yuewei, NIU Liyuan, WANG Yanting, FAN Wenjing, NIU Zejun
doaj   +1 more source

Construction and reliability and validity of the Chinese revised vascular quality of life questionnaire

open access: yes陆军军医大学学报
Objective To translate and optimize the vascular quality of life questionnaire (VascuQOL) into Chinese, and to obtain a VascuQOL version which is adapted to Chinese culture and language.
LU Sha, LIU Liping, XIANG Bo
doaj   +1 more source

Microarray Expression Profile and Bioinformatic Analysis of Circular RNA in Human Arteriosclerosis Obliterans

open access: yesPharmacogenomics and Personalized Medicine, 2023
Yu Zhou,1,* Huoying Cai,1,* Lin Huang,1,* Mingshan Wang,1 Ruiming Liu,2 Siwen Wang,1 Yuansen Qin,1 Chen Yao,1 Zuojun Hu1 1Division of Vascular Surgery, National-Guangdong Joint Engineering Laboratory for Diagnosis and Treatment of Vascular ...
Zhou Y   +8 more
doaj  

A risk predictor of restenosis after superficial femoral artery stent implantation: relevance of mean platelet volume

open access: yesBMC Cardiovascular Disorders, 2020
Background To investigate the relationship between an increase in the pre- and post-operative mean platelet volume (MPV) and superficial femoral artery in-stent restenosis (ISR) rate.
Yao Bo Yang   +17 more
doaj   +1 more source

Correlation of the levels of inflammatory factors and miRNAs in blood with the clinical stage of lo-wer extremity atherosclerotic occlusive disease in elderly patients [PDF]

open access: yes精准医学杂志
Objective To investigate the correlation of interleukin (IL)-6, interleukin-8 (IL-8), tissue inhibitor of me-talloproteinase-1 (TIMP-1), miRNA-128, and miRNA-381 with the clinical stage of lower extremity atherosclerotic occlusive di-sease (LEASO) in ...
ZHAO Rui, ZHAO Fule, OU Minghui
doaj   +1 more source

A Case of Acquired Factor V Deficiency in a Hemodialysis Patient: A Case Report With Literature Review

open access: yesIJU Case Reports, Volume 9, Issue 1, January 2026.
ABSTRACT Introduction Acquired factor V (FV) deficiency is a rare bleeding disorder requiring careful management, especially in hemodialysis (HD) patients who regularly receive anticoagulants. We present a case of recurrent acquired FV deficiency in a dialysis patient.
Akihiko Sugino   +9 more
wiley   +1 more source

Candidate Biomarkers for Crohn’s Disease: Hub Genes and Regulatory miRNAs Identified by Bioinformatics Analysis

open access: yesBiochemistry Research International, Volume 2026, Issue 1, 2026.
Background Crohn’s disease (CD) is a chronic, complex inflammatory condition that can affect the entire digestive tract, most commonly the terminal ileum. The exact cause of CD remains unknown. Bioinformatics was used in this study to identify the differentially expressed genes (DEGs) and microRNAs (miRNAs) that show potential as diagnostic and ...
Han Wang   +2 more
wiley   +1 more source

Indirect Disaster‐Related Deaths Among Hemodialysis Patients Following the Fukushima Daiichi Nuclear Power Plant Accident

open access: yesCase Reports in Nephrology, Volume 2026, Issue 1, 2026.
Introduction Disaster‐related deaths (DRDs) are indirect fatalities caused by physical or psychological stress during evacuation. Patients undergoing hemodialysis (HD) face increased vulnerability during disasters due to reduced dialysis frequency, elevated mental stress, and limited access to medical resources.
Ryoma Yoshida   +21 more
wiley   +1 more source

Association of the Fibrosis‐4 Index With Indices of Atherosclerosis in Patients With Type 2 Diabetes: An Exploratory Subanalysis of a Prospective Observational Cohort Study

open access: yesJournal of Diabetes Research, Volume 2026, Issue 1, 2026.
Background Metabolic dysfunction–associated steatotic liver disease (MASLD) is characterized by insulin resistance and metabolic syndrome, with type 2 diabetes mellitus (T2DM) as a major risk factor. Additionally, MASLD has been linked to liver fibrosis, which is associated with increased cardiovascular risk. Although noninvasive liver fibrosis markers
Kenichi Tanaka   +13 more
wiley   +1 more source

Nanomedicines Against Mitochondrial Dysfunction‐Induced Metabolic Diseases

open access: yesAdvanced Science, Volume 12, Issue 48, December 29, 2025.
Mitochondrial dysfunction is central to metabolic diseases. Nanomedicine offers transformative approaches for restoring function via targeted delivery, responsive release, and multimodal therapy. This review outlines the pathological basis, nanocarrier design, organelle‐specific targeting, recent advances, and future clinical translation challenges ...
Ke Xu   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy